AFT Pharmaceuticals Limited (ASX:AFP) Annual Report 2020



The latest annual report of AFT Pharmaceuticals Limited (AFP) was published on 31 Mar 2020. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - AFP Annual Results

Amounts in NZD

Total Revenue
105.6M
Gross Profit
48.27M
EBIT
11.5M
Net Tangible Assets
-9M
Net Income
12.69M
Capital Expenditures
-92k

AFP Income Statement 2020 Annual Report

As per the latest Income Statement of AFP, the Net revenue increased by $20.47M (24%) compared to the previous period. The operating income in 2020 increased by $4.87M (73%). The net income as per the annual report was 12.69M which increased by $15.12M (623%) compared to previous year.

Income Statement Report (2020/2019)

20202019
Total Revenue105.6M85.13M
Gross Profit48.27M40.73M
Operating Income11.5M6.64M
Income Before Tax12.88M-2.26M
Net Income12.69M-2.43M

Balance Sheet - AFP 2020 Annual Report

Read further: AFP Balance Sheet Detailed Analysis

The latest balance sheet from annual result of AFT Pharmaceuticals Limited showed the company reduced the cash on balance sheet by $-797000 (-12%). The Net tangible assets of AFP on the balance sheet were at -9M which is $-812000 (-10%) less than previous annual report. The total stockholder equity also increased by $11.74M (223%) compared to previous reporting period.

Balance Sheet Statement Report (2020/2019)

20202019
Cash6.12M6.92M
Total Assets87.05M 63.59M
Long Term Debt41.2M-
Total Liabilities69.8M 58.5M
Total Shareholder Equity6.46M-5.27M
Net Tangible Assets-9M-8.19M

Cash Flow Statement - AFP 2020 Annual Report

The 2020 annual cash flow statement of AFT Pharmaceuticals Limited showed that the net income increased by $15.12M (623%) compared to previous reporting period. Also the capital expenditure of AFP increased by $48000 (34%).

As of 2020, the total cash from investing activities was -6.56M and total cash from financing activities was -9.12M.

Cash Flow Statement Report (2020/2019)

20202019
Net Income12.69M-2.43M
Capital Expenditures-92k-140k
Dividends Paid-566k-134k
Total Cash From From Investing Activities-6.56M-4.88M
Total Cash From From Financing Activities-9.12M3.72M

AFT Pharmaceuticals Limited Annual Report History

Income Statement

Income Statement history of AFT Pharmaceuticals Limited (ASX:AFP)

31 Mar 202031 Mar 201931 Mar 201831 Mar 2017
Total Revenue105.6M85.13M81.18M69.2M
Cost Of Revenue57.33M44.4M45.88M43.21M
Gross Profit48.27M40.73M35.3M26M
Research Development333k914k6.52M9.22M
Selling General Administrative36.97M35.42M38.55M33.82M
Non Recurring----
Other Operating Expenses-535k-2.24M-1.13M-2.11M
Total Operating Expenses94.09M78.49M89.82M84.14M
Operating Income11.5M6.64M-8.64M-14.94M
Total Other Income Expense Net1.38M-8.9M-4.02M-3.4M
Ebit11.5M6.64M-8.64M-14.94M
Interest Expense-6.96M-5.39M-3.5M-3.19M
Income Before Tax12.88M-2.26M-12.67M-18.33M
Income Tax Expense185k168k58k58k
Minority Interest----
Net Income From Continuing Ops12.69M-2.43M-12.72M-18.39M
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income12.69M-2.43M-12.72M-18.39M
Net Income Applicable To Common Shares11.7M-3.36M-13.62M-18.39M

Balance Sheet Statement

Balance Sheet Statement history of AFT Pharmaceuticals Limited (ASX:AFP)

31 Mar 202031 Mar 201931 Mar 201831 Mar 2017
Cash6.12M6.92M6.77M15.9M
Net Receivables22.63M16.28M14.78M14.02M
Inventory22.73M25.16M24.41M22.2M
Other Current Assets514k-176k-
Total Current Assets55.34M51.26M48.31M54.15M
Property Plant Equipment4.03M357k330k386k
Intangible Assets15.46M2.91M2.65M2.55M
Other Assets12.23M6.03M3.17M610k
Deferred Long Term Asset Charges705k705k708k610k
Total Assets87.05M63.59M56.6M58.33M
Accounts Payable8.62M6.67M7.33M10.83M
Short Long Term Debt2M41.75M--
Other Current Liab7.39M6.63M8.05M2.26M
Long Term Debt41.2M-30.65M23.43M
Deferred Long Term Liab11.52M5.33M2.46M-
Total Current Liabilities25.1M58.5M18.61M15.43M
Total Liab69.8M58.5M49.26M38.85M
Common Stock57.06M57.06M57.06M55.99M
Retained Earnings-49.27M-61.01M-57.64M-44.02M
Treasury Stock-1.32M-1.33M-1.68M-1.62M
Other Stockholder Equity-1.32M-1.33M-1.68M-1.62M
Total Stockholder Equity6.46M-5.27M-2.27M10.35M
Net Tangible Assets-9M-8.19M-4.92M7.8M

Cash Flow Statement

Cash Flow Statement history of AFT Pharmaceuticals Limited (ASX:AFP)

31 Mar 202031 Mar 201931 Mar 201831 Mar 2017
Net Income12.69M-2.43M-12.72M-18.39M
Depreciation956k243k241k242k
Change To Netincome82k7.85M3.34M1.36M
Change To Account Receivables-7.3M-2.05M-1.08M-5.27M
Change To Liabilities5.88M-1.88M3.17M1.51M
Change To Inventory2.42M-746k-2.21M1.26M
Total Cash From Operating Activities14.88M1.07M-9.17M-19.06M
Capital Expenditures-92k-140k-70k-122k
Total Cashflows From Investing Activities-6.56M-4.88M-5.86M-1.6M
Dividends Paid-566k-134k-412k-412k
Net Borrowings-2.65M7.42M7.13M7.13M
Other Cashflows From Financing Activities-5.9M-3.56M-1.93M-82k
Total Cash From Financing Activities-9.12M3.72M5.86M9.04M
Effect Of Exchange Rate5k240k24k-457k
Change In Cash-797k146k-9.13M-12.07M
Issuance Of Stock3k3k1.06M1.06M